News
CELZ
1.030
+6.19%
0.060
Creative Medical Technology Expands Control of BioDefense Subsidiary
TipRanks · 1d ago
Creative Medical Technology Acquires 4M Additional BioDefense Stock For $200K Cash And 1M Shares, Raising Ownership To 80%
Benzinga · 1d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 4d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 5d ago
Weekly Report: what happened at CELZ last week (0914-0918)?
Weekly Report · 6d ago
Creative Medical Technology Announces Filing Of New US Provisional Patent Application To Expand IP Protection Surrounding Ultrasome, Its Proprietary Cell-Free Regenerative Medicine Platform
Benzinga · 09/17 13:06
Creative Medical files new U.S. provisional patent application for Ultrasome
TipRanks · 09/17 13:05
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 09/14 21:06
Weekly Report: what happened at CELZ last week (0907-0911)?
Weekly Report · 09/14 10:05
Weekly Report: what happened at CELZ last week (0831-0904)?
Weekly Report · 09/07 10:00
Creative Medical Expands Authorized Shares and Warrant Exercise
TipRanks · 08/31 20:31
Weekly Report: what happened at CELZ last week (0824-0828)?
Weekly Report · 08/31 10:06
Weekly Report: what happened at CELZ last week (0817-0821)?
Weekly Report · 08/24 10:06
Roth believes Creative Medical’s ADAPT trial in CLBO ‘likely to succeed’
TipRanks · 08/20 17:50
Creative Medical Completes ADAPT Trial Enrollment; Advances Olastrocel; Stock Up
NASDAQ · 08/20 13:47
Creative Medical completes enrollment in ADAPT clinical trial
TipRanks · 08/20 13:35
Weekly Report: what happened at CELZ last week (0810-0814)?
Weekly Report · 08/17 10:07
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 08/10 12:06
Weekly Report: what happened at CELZ last week (0803-0807)?
Weekly Report · 08/10 10:03
Why Avalon Holdings Shares Are Trading Higher By More Than 10%; Here Are 20 Stocks Moving Premarket
Benzinga · 08/10 08:59
More
Webull provides a variety of real-time CELZ stock news. You can receive the latest news about Creative Med Technology Hldgs through multiple platforms. This information may help you make smarter investment decisions.
About CELZ
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.